Brainstorm cell therapeutics posts q3 loss per share of $0.25

Brainstorm announces financial results for the third quarter of 2019 and provides a corporate update.q3 loss per share $0.25.quarter end cash, cash equivalents, and short-term bank deposits were $2.1 million.q3 earnings per share view $-0.22 -- refinitiv ibes data.

BCLI Ratings Summary

BCLI Quant Ranking